glutamic acid has been researched along with 2019 Novel Coronavirus Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 12 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Bakky, MS; Abdellatif, AAH; Amin, E; Faris, TM | 1 |
| Alvarenga, AC; Appel, RM; Arima, EC; Ayache, R; Budib, MA; D'Amora, P; Diaz, RS; Evans, SS; Júnior, SS; Martins, WG; Nagourney, RA; Palma, AM; Pontes, HBD; Salzgeber, MB; Silva, FC; Silva, IDCG; Silva, NLF; Silva, RMS | 1 |
| Auguet, T; Benavent-Bofill, C; Boqué, C; Burgos, J; Buzón, MJ; García-Pardo, G; Gómez-Bertomeu, F; Gutiérrez-Valencia, A; López-Cortés, LF; Martí, A; Mestre, MT; Olona, M; Peraire, J; Reverté, L; Ruiz-Mateos, E; Rull, A; Vidal, F; Viladés, C; Yeregui, E | 1 |
| Chen, JH; Chen, WW; Cole, R; Hao, PF; Jalloh, MB; Li, C; Li, XK; Liu, W; Lu, QB; Sevalie, S; Tu, B; Xu, B; Xu, W; Yan, YF; Zhang, XA; Zhao, GY; Zheng, JJ | 1 |
| Germán-Acacio, JM; Gómez-Martín, D; Maravillas-Montero, JL; Mejía-Domínguez, NR; Páez-Franco, JC; Pérez-Fragoso, A; Ponce-de-León, A; Tamez-Torres, KM; Torres-Ruiz, J; Ulloa-Aguirre, A | 1 |
| Cao, L; Gui, H; Han, M; He, M; Huang, S; Huang, Y; Jia, W; Liu, J; Qiu, H; Wang, Y; Xiao, Y; Zhang, N | 1 |
| Holton, KF; Kao, A; Sarlo, GL | 1 |
| Hramov, AE; Kazantsev, VB; Stasenko, SV | 1 |
| Durante, W | 1 |
| Adams, L; Bennett, M; Harvey, R; Proust, A; Queval, CJ; Wilkinson, RJ | 1 |
| Zalsman, G | 1 |
| Balcioglu, YH; Sen, M; Yesilkaya, UH | 1 |
3 review(s) available for glutamic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review).
Topics: Antidepressive Agents; COVID-19; Cytokine Release Syndrome; Depressive Disorder, Major; Glutamic Acid; Humans; Oxidative Stress | 2021 |
Dysregulation of glutamine/glutamate metabolism in COVID-19 patients: A metabolism study in African population and mini meta-analysis.
Topics: Biomarkers; COVID-19; Glutamic Acid; Glutamine; Humans; Metabolomics | 2023 |
Glutamine Deficiency Promotes Immune and Endothelial Cell Dysfunction in COVID-19.
Topics: COVID-19; Endothelial Cells; Glutamic Acid; Glutaminase; Glutamine; Humans; Vascular Diseases | 2023 |
1 trial(s) available for glutamic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Investigation of the low glutamate diet as an adjunct treatment for pediatric epilepsy: A pilot randomized controlled trial.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; COVID-19; Diet; Drug Resistant Epilepsy; Epilepsy; Glutamic Acid; Humans; Pilot Projects; Seizures; Young Adult | 2023 |
8 other study(ies) available for glutamic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
Topics: Adult; Aged; Area Under Curve; Carnitine; Citrulline; COVID-19; Female; Glutamic Acid; Humans; Kynurenine; Male; Metabolome; Metabolomics; Middle Aged; Ornithine; Risk Factors; ROC Curve; SARS-CoV-2; Severity of Illness Index; Tryptophan | 2021 |
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.
Topics: Alpha-Globulins; Biomarkers; Cholesterol Esters; COVID-19; Glutamic Acid; Humans; Severity of Illness Index; Treatment Outcome | 2022 |
Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology.
Topics: Amino Acids; COVID-19; Cystine; Gas Chromatography-Mass Spectrometry; Glutamic Acid; Glutamine; Homeostasis; Humans; Hypoxia; Male; Oxidation-Reduction; Oxygen; Proline; Reactive Oxygen Species; SARS-CoV-2 | 2022 |
Metabolomics-based investigation of SARS-CoV-2 vaccination (Sinovac) reveals an immune-dependent metabolite biomarker.
Topics: Biomarkers; COVID-19; COVID-19 Vaccines; Cytokines; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Indoles; Metabolomics; SARS-CoV-2; Succinic Acid; Taurine; Vaccination; Viral Vaccines | 2022 |
Loss of neuron network coherence induced by virus-infected astrocytes: a model study.
Topics: Astrocytes; Brain; COVID-19; Glutamic Acid; Humans; Models, Neurological; Neurons | 2023 |
Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
Topics: Blood-Brain Barrier; COVID-19; Endothelial Cells; Glutamic Acid; Humans; SARS-CoV-2 | 2023 |
Neurobiology of suicide in times of social isolation and loneliness.
Topics: Betacoronavirus; Brain; Coronavirus Infections; COVID-19; Functional Neuroimaging; Gene-Environment Interaction; Glutamic Acid; Humans; Hypothalamo-Hypophyseal System; Loneliness; Pandemics; Pituitary-Adrenal System; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Social Environment; Social Isolation; Stress, Psychological; Suicidal Ideation; Suicide | 2020 |
COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway.
Topics: Adult; Aspartic Acid; Cognitive Dysfunction; COVID-19; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Prefrontal Cortex; Signal Transduction | 2021 |